5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.81▲ | 0.81▲ | 0.81▲ | 0.75▲ | 0.71▲ |
MA10 | 0.80▲ | 0.80▲ | 0.78▲ | 0.73▲ | 0.72▲ |
MA20 | 0.79▲ | 0.76▲ | 0.76▲ | 0.70▲ | 0.69▲ |
MA50 | 0.76▲ | 0.74▲ | 0.73▲ | 0.71▲ | 0.91▼ |
MA100 | 0.74▲ | 0.69▲ | 0.71▲ | 0.70▲ | 2.34▼ |
MA200 | 0.71▲ | 0.71▲ | 0.72▲ | 0.89▼ | 17.96▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.006▲ | 0.008▲ | 0.010▲ | 0.038▲ |
RSI | 72.658▲ | 70.347▲ | 67.861▲ | 61.779▲ | 49.655▼ |
STOCH | 100.000▲ | 100.000▲ | 100.000▲ | 66.234 | 51.573 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -8.543▲ | -21.739▲ |
CCI | 201.001▲ | 131.030▲ | 121.264▲ | 187.872▲ | 97.339 |
Monday, April 28, 2025 09:00 AM
Investors might want to bet on PAVmed Inc. (PAVM), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...
|
Friday, April 25, 2025 09:58 AM
(NASDAQ:PAVM), a medical device company with a market ... following the acquisition of Marcum’s attest business by CBIZ (NYSE:CBZ) CPAs P.C. on November 1, 2024. Subsequently, with the approval ...
|
Thursday, April 24, 2025 09:05 AM
Study shows Lucid's EsoGuard test detects esophageal precancer in at-risk patients without symptoms. Read more here.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.77 | 0.837 | 0.755 | 0.82 | 143,455 |
30/04/25 | 0.712 | 0.7531 | 0.70 | 0.7246 | 41,006 |
29/04/25 | 0.7263 | 0.755 | 0.708 | 0.729 | 20,100 |
28/04/25 | 0.77 | 0.77 | 0.72 | 0.72 | 45,023 |
25/04/25 | 0.78 | 0.78 | 0.735 | 0.76 | 32,514 |
24/04/25 | 0.77 | 0.7999 | 0.7211 | 0.7547 | 81,844 |
23/04/25 | 0.6703 | 0.77 | 0.6703 | 0.77 | 142,527 |
22/04/25 | 0.6723 | 0.7374 | 0.64 | 0.70 | 43,542 |
21/04/25 | 0.73 | 0.73 | 0.64 | 0.6551 | 85,795 |
17/04/25 | 0.67 | 0.7135 | 0.67 | 0.71 | 18,135 |
|
|
||||
|
|
||||
|
|